Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Farrelly

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Chest|June 30, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT studyMonica L Mullin, Andrew W Creamer, Amyn Bhamani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programmeJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-upAmyn Bhamani, Carolyn Horst, Fanta Bojang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2022
The reporting of pulmonary nodule results by letter in a lung cancer screening settingJennifer L Dickson, Amyn Bhamani, Samantha L Quaife, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Thorax|June 2, 2025
Performance of volume and diameter thresholds in malignancy prediction of solid nodules in lung cancer screeningAndrew W Creamer, Carolyn Horst, Ruth Prendecki, et al.
Thorax|July 21, 2022
Telephone risk-based eligibility assessment for low-dose CT lung cancer screeningJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Chest|June 30, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT studyMonica L Mullin, Andrew W Creamer, Amyn Bhamani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2022
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programmeJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Lung Cancer (Amsterdam, Netherlands)|January 9, 2023
The SUMMIT Study: Utilising a written 'Next Steps' information booklet to prepare participants for potential lung cancer screening results and follow-upAmyn Bhamani, Carolyn Horst, Fanta Bojang, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2022
The reporting of pulmonary nodule results by letter in a lung cancer screening settingJennifer L Dickson, Amyn Bhamani, Samantha L Quaife, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
The Lancet. Oncology|June 28, 2015
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trialAmit M Oza, Adrian D Cook, Jacobus Pfisterer, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
Pageof 4